PERITONEAL MALIGNANT MESOTHELIOMA
Clinical trials for PERITONEAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PERITONEAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New way to deliver chemo shows promise for rare abdominal cancer
Disease control CompletedThis study tested a chemotherapy drug called paclitaxel given directly into the abdomen for people with a rare cancer of the lining of the belly (peritoneal mesothelioma) who cannot have standard surgery. Seven participants received weekly doses to find the safest amount and see …
Matched conditions: PERITONEAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Immune drug shows promise against rare cancer
Disease control CompletedThis study tested a drug called pembrolizumab in 65 people with malignant mesothelioma, a rare cancer of the lining around the lungs or abdomen. The drug works by helping the body's immune system attack cancer cells. The goal was to see if it could shrink tumors or slow the disea…
Matched conditions: PERITONEAL MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 19, 2026 11:48 UTC